RM-131
Sponsors
Motus Therapeutics, Inc.
Conditions
Anorexia NervosaChronic ConstipationConstipationDiabetes MellitusDiabetes Mellitus ComplicationsDiabetes Mellitus Type 1 and 2Gastrointestinal Motility DisorderGastroparesis
Phase 1
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
CompletedNCT01394055
Start: 2011-07-31End: 2012-12-31Updated: 2016-09-22
Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation
CompletedNCT02137642
Start: 2014-08-31End: 2014-11-30Updated: 2016-09-22
Phase 2
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
CompletedNCT01571297
Start: 2012-04-30End: 2013-09-30Updated: 2016-09-23
Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa
CompletedNCT01642550
Start: 2012-11-30End: 2015-03-31Updated: 2016-09-23
Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation
CompletedNCT01781104
Start: 2013-03-31End: 2014-10-31Updated: 2016-09-23
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
TerminatedNCT01955616
Start: 2013-09-30End: 2015-09-30Updated: 2016-09-23